Cochlear CHEOF Stock
Cochlear Price Chart
Cochlear CHEOF Financial and Trading Overview
| Cochlear stock price | 96.79 USD |
| Previous Close | 96.75 USD |
| Open | 96.75 USD |
| Bid | 96 USD x 30000 |
| Ask | 100.25 USD x 30000 |
| Day's Range | 96.75 - 96.75 USD |
| 52 Week Range | 64.39 - 207.71 USD |
| Volume | 412 USD |
| Avg. Volume | 1.23K USD |
| Market Cap | 6.33B USD |
| Beta (5Y Monthly) | 0.262 |
| PE Ratio (TTM) | 59.72222 |
| EPS (TTM) | 1.62 USD |
| Forward Dividend & Yield | 1.84 (1.89%) |
| Ex-Dividend Date | September 21, 2026 |
| 1y Target Est | N/A |
CHEOF Valuation Measures
| Enterprise Value | 6.35B USD |
| Trailing P/E | 59.72222 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.69524 |
| Price/Book (mrq) | 5.0625343 |
| Enterprise Value/Revenue | 2.706 |
| Enterprise Value/EBITDA | 13.237 |
Trading Information
Cochlear Stock Price History
| Beta (5Y Monthly) | 0.262 |
| 52-Week Change | -53.15% |
| S&P500 52-Week Change | 19.66% |
| 52 Week High | 207.71 USD |
| 52 Week Low | 64.39 USD |
| 50-Day Moving Average | 85.42 USD |
| 200-Day Moving Average | 124.9 USD |
CHEOF Share Statistics
| Avg. Volume (3 month) | 1.23K USD |
| Avg. Daily Volume (10-Days) | 70 USD |
| Shares Outstanding | 65.4M |
| Float | 65.14M |
| Short Ratio | N/A |
| % Held by Insiders | 0.64% |
| % Held by Institutions | 66.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 3.45 |
| Trailing Annual Dividend Yield | 3.56% |
| 5 Year Average Dividend Yield | 143.00% |
| Payout Ratio | 1.9094 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 6.27% |
| Operating Margin (ttm) | 14.33% |
| Gross Margin | 70.69% |
| EBITDA Margin | 20.44% |
Management Effectiveness
| Return on Assets (ttm) | 9.70% |
| Return on Equity (ttm) | 7.98% |
Income Statement
| Revenue (ttm) | 2.35B USD |
| Revenue Per Share (ttm) | 35.89 USD |
| Quarterly Revenue Growth (yoy) | 0.80% |
| Gross Profit (ttm) | 1.66B USD |
| EBITDA | 479.9M USD |
| Net Income Avi to Common (ttm) | 147.3M USD |
| Diluted EPS (ttm) | 1.62 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 187.7M USD |
| Total Cash Per Share (mrq) | 2.87 USD |
| Total Debt (mrq) | 212.7M USD |
| Total Debt/Equity (mrq) | 12.22 USD |
| Current Ratio (mrq) | 2.151 |
| Book Value Per Share (mrq) | 19.110981 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 368M USD |
| Levered Free Cash Flow (ttm) | 313.59M USD |
Profile of Cochlear
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | 1 University Avenue |
| ZIP | 2109 |
| Phone | 61 2 9428 6555 |
| Website | https://www.cochlear.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 5400 |
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist; Cochlear Remote Check; and Cochlear Link. It offers its products and services under the Cochlear, Nucleus, Nexa, Osia, and Cochlear Baha brands. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Q&A For Cochlear Stock
What is a current CHEOF stock price?
Cochlear CHEOF stock price today per share is 96.79 USD.
How to purchase Cochlear stock?
You can buy CHEOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cochlear?
The stock symbol or ticker of Cochlear is CHEOF.
Which industry does the Cochlear company belong to?
The Cochlear industry is Medical Devices.
How many shares does Cochlear have in circulation?
The max supply of Cochlear shares is 65.4M.
What is Cochlear Price to Earnings Ratio (PE Ratio)?
Cochlear PE Ratio is 59.74691400 now.
What was Cochlear earnings per share over the trailing 12 months (TTM)?
Cochlear EPS is 1.62 USD over the trailing 12 months.
Which sector does the Cochlear company belong to?
The Cochlear sector is Healthcare.
